|
Intensive blood glucose control improves outcome
and mortality in a heterogeneous population of critical care patients.
|
Intensive control of blood glucose improves mortality and
reduces the risk of renal dysfunction in a mixed medical/surgical ICU.
Level of evidence:
2- (Cohort study with a high risk of bias) |
Citation/s:
Effect of an Intensive Glucose Management Protocol on the Mortality of
Critically Ill Patients: Mayo Clin Proc. August 2004: 79(8): 992-1000
Lead author's name and fax: Dr James Krinsley,
MD, Director of Critical Care, The Stamford Hospital, 190 W Broad St., CT 06902.
mailto:Jkrinsley@stamhealth.org
Three-part Clinical Question: In a heterogeneous
patient population does an intensive glucose management protocol improve the
outcome of critically ill adult patients?
Search Terms: e-library, critical care, insulin
and outcome/mortality
The Study: Cohort Study.
The Study Patients: All consecutive patients admitted to the ICU after
institution of the protocol. Comparison with historical controls.
Exposure of Interest: Intensive glucose management protocol
using both s/c and then iv insulin to maintain a blood glucose of less than
140mg/dL (7.77 mmol/L). The protocol was discontinued on discharge from the ICU.
The Outcome: (a) Mortality. (b) Renal dysfunction:
Defined as initial serum creatinine level of 1.5 mg/dL or lower with maximum
serum creatinine level of 2.5 mg/dL or higher or initial serum creatinine level
lower than 1.5mg/dL with maximum serum creatinine level 2 or more times the
initial value.
Subjects were not defined and similar in other
important ways. The exposures and outcomes were neither objective nor measured
blind. Follow-up was long enough; follow-up was complete enough.
The Evidence (Mortality):
|
|
|
Non-survivors |
Survivors |
|
|
|
Number |
Proportion |
Number |
Proportion |
|
Intensive glucose management... |
Yes |
118 |
0.15 |
682 |
0.85 |
|
No |
167 |
0.21 |
633 |
0.79 |
|
Relative Risk: |
0.71 |
95% CI: |
0.68 to 0.73 |
|
|
Number Needed to Harm: |
-16 |
|
|
|
|
Chi Square |
10.67 |
|
|
|
The Evidence (Renal dysfunction):
|
|
|
Renal dysfunction |
|
|
|
Present |
Absent |
|
|
|
Number |
Proportion |
Number |
Proportion |
|
|
Yes |
3 |
0.00 |
797 |
1.00 |
|
No |
12 |
0.01 |
788 |
0.98 |
|
Relative Risk: |
0.25 |
95% CI: |
0.23 to 0.27 |
|
|
Number Needed to Harm: |
-89 |
|
|
|
|
Chi Square |
6.73 |
|
|
|
EBM summary questions:
1) Do the methods allow accurate testing of the
hypothesis? No, although the study was of a sufficiently large size, it was
not a randomised controlled trial and as such does not represent the gold
standard for the analysis of this question. The study fails to demonstrate
whether the improved outcome is due to improved glycaemic control or due to
another confounding (historical) factor.
2) Do the statistical tests correctly test the results to allow differentiation
of statistically significant results? Yes, it utilizes the correct
statistical techniques and is sufficiently powered, with the main outcome
demonstrating a statistically significant p-value
3) Are conclusions valid in light of the results? Yes, although they do
recognize the limits of their study due to the selection of their control group.
4) Did results get omitted, and why? No
5) Did they suggest areas of further research? Yes, they suggest a
randomised controlled trial and also further research in to the underlying
mechanisms behind the improvement in survival.
6) Did they make any recommendations based on the results and were they
appropriate? Yes, they recommend the adoption of a similar strategy, which
given evidence from other studies, the interventions low cost and the potential
benefits is wholly appropriate.
7) Is the study relevant to my clinical practice? Yes, this study deals with
critically ill patients within the intensive care with a wide variety of
pathology
8) What level of evidence does
this study represent? 2-
9) What grade of recommendation
can I make on this result alone? No recommendation can be made on this study
alone
10) What
grade of recommendation can
I make when this study is considered along with other available evidence? A
11) Should I change my practice because of these
results? Yes, given that this study when considered in association
with other works ( van de Berghe), offers a relatively cheap and efficient way
of improving outcome in ICU, not specific to any particular disease process.
12) Should I audit my current practice because of these results? Yes as
improved glycaemic control has been shown to improve mortality and is easily
monitored and audited.
Appraised by: Dr. Paul McConnell c/o Dept. of
Anaesthesia Royal Alexandra Hospital, Corsebar Road, Paisley; 03 August 2005
Email:
joe_jitsu_uk@yahoo.co.uk
Reviewed and Edited by CC & KR
Citation:
EBM Critical Appraisals. Scottish Intensive Care Society EBM Group. McConnell P.
2005. Effect of an Intensive Glucose Management Protocol on the Mortality of
Critically Ill Patients: Mayo Clin Proc. August 2004: 79(8): 992-1000.
Kill or update
By: August 2006
Printer
friendly view
©SICS EBM 2005
|